Samantha Stone Barrett, MPH’s Post

Uncover the milestones in #MedTech innovation with Mecomed's 2023 Annual Report, marking a year of creating strategic patient-centric alliances, shaping MedTech #regulations, and a strengthened commitment to #compliance. Our Board of Directors' progressive vision and Secretariat’s hard work have been instrumental in these achievements, underscoring the collaborative nature of our association. The comprehensive insights from all our committees further illustrate the broad spectrum of #Mecomed’s strategic efforts driving patient care forward in the MEA region. Read the full report here: https://bit.ly/3OC3s2Y

Are you aiming to enhance productivity and efficiencies in your #medtech study? IQVIA MedTech can help you to achieve your goals through supporting your journey to validation for clinical use. Discover how by reading this case study: https://bit.ly/44I4qS7

Are you aiming to enhance productivity and efficiencies in your #medtech study? IQVIA MedTech can help you to achieve your goals through supporting your journey to validation for clinical use. Discover how by reading this case study: https://bit.ly/4cZFR6B

One of the aspects I love most about my work is supporting the FDA in scaling their decision-making—making it more consistent and actionable. But here’s the reality: while decisions should be driven primarily by scientific results, they often hinge on benefit-risk trade-offs. And those trade-offs aren’t purely biological—they’re dependent on individual values and quality of life. As I shared on Inside MedTech Innovation, “What is good? What risk is tolerable?” This delicate balance is what ensures healthcare innovation serves patients in the best way possible. 🎧 Listen to the full episode here: https://lnkd.in/ebGPJxVD #MedTech #RegulatoryInnovation #DecisionScience #HealthcareLeadership #InsideMedTechInnovation

One of the aspects I love most about my work is supporting the FDA in scaling their decision-making—making it more consistent and actionable. But here’s the reality: while decisions should be driven primarily by scientific results, they often hinge on benefit-risk trade-offs. And those trade-offs aren’t purely biological—they’re dependent on individual values and quality of life. As I shared on Inside MedTech Innovation, “What is good? What risk is tolerable?” This delicate balance is what ensures healthcare innovation serves patients in the best way possible. 🎧 Listen to the full episode here: https://lnkd.in/ebGPJxVD #MedTech #RegulatoryInnovation #DecisionScience #HealthcareLeadership #InsideMedTechInnovation

Can't miss discussion on the future of complaint handling in MedTech!

As medtech companies scale their business, they are faced with increases in complaint volumes coupled with the demands to reduce the cost of quality. Learn from industry titans Cardinal Health, PwC and Veeva MedTech on how to achieve quality excellence with a purpose built solution.

Last chance to join us for our VIRTUAL Panel Discussion for Wednesday October 30th 12:00PM EST. SIGN UP BELOW ⬇ 🚀 MedTech 2025: Prepare for What's Next 🚀 🔴 SIGN UP IN THE LINK BELOW 🔴 ➡https://lnkd.in/gC3bi3Fc We are excited to be hosting this free event on October 30, 2024, at 12 PM Eastern, where we’ll dive deep into the future of MedTech with an expert panel, discussing: 🔹 Which Regulatory changes are coming in 2025, and how to plan for them? 🔹 How to navigate challenging times in the #MedTech space in a world of uncertainty. 🔹 Strategies on how to get products from concept to commercialization In this rapidly evolving landscape, staying ahead is crucial. Whether you're driving innovation or shaping patient care, this discussion will provide invaluable insights to help you thrive. 🗓️ Save the Date: October 30, 2024, at 11 AM Central 💡 Learn from Leading Experts in MedTech 📈 Explore Trends that Will Shape the Industry's Future #MedTech2025 #MedTechInnovation #MedicalDevice #Regulatory #Clinical #IndustryTransformation #BioBridges

#ICYMI: Consultants Corner is where Market Pathways checks in with independent experts about questions they are answering or challenges they are solving for clients on the front lines of medtech regulatory, reimbursement, and market access. Standards promote consensus and efficiency, but small companies face barriers in identifying, leveraging, and helping shape standards that can benefit their business. In this edition of Consultants Corner, Elisabeth George offers advice from her years of experience putting standards to use in medtech: https://bit.ly/4e3PkL6 #marketresearch #policyresearch #marketaccess #medtech

Looking forward to making some new connections and engaging in the exciting topics being discussed at the Digital Health World Congress, this week. If you have a digital healthcare challenge you'd like to discuss, or would like to learn more about #KinneirDufort's capabilities, please drop me a line or catch me there!